Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-000302
Filing Date
2025-01-31
Accepted
2025-01-31 18:47:49
Documents
1
Period of Report
2025-01-29

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5547
  Complete submission text file 0000905148-25-000302.txt   7002
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIRACTA THERAPEUTICS, INC. 2533 SOUTH COAST HWY., STE. 210 CARDIFF CA 92007
Business Address
Rojkjaer Lisa (Reporting) CIK: 0001846460 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 25579953